A Multicenter, Phase 2, Randomized, Open-label, Active-controlled, Parallel Group Clinical Trial to Investigate the Safety, Tolerability, and Efficacy of Different Dose Levels of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Individuals with Turner Syndrome
What is the goal of the study?
To evaluate and compare three different lonapegsomatropin doses administered once-weekly to daily somatropin in promoting linear growth in prepubertal individuals with Turner Syndrome (TS) at 26 weeks of treatment
Who can participate in the study?
Please contact the study team listed below to learn more.